An emergent goal of Shanghai’s ongoing construction as a science and innovation center is to focus on key areas such as biomedicine, artificial intelligence and integrated circuits. The goal is to enhance innovation curation capabilities, to make Shanghai strive to become an important source of new global academic ideas, new scientific discoveries, new technological inventions and new industrial directions, and to continuously enhance the city’s capacity and core competitiveness. The rapid progress of the construction of Zhangjiang Comprehensive National Science Center and Zhangjiang Science City has greatly facilitated the development of Zhangjiang as a national biomedical innovation base.

On the one hand, the Shanghai Clinical Research and Trial Center can fully rely on the geographical advantage of the concentration of large scientific facilities in Zhangjiang to enhance the level of clinical research; on the other hand, it can fully rely on the achievements of ShanghaiTech University in the field of biomedicine and the advantages of the institutional mechanism to build a platform-type clinical research center, attracting municipal hospitals, scientific research units, drug research and development enterprises, medical equipment research and development enterprises in the city.

Building the Shanghai Clinical Research and Trial Center will greatly promote and unleash the innovation capacity of Shanghai’s clinical practitioners, greatly enhance the city’s ability to generate medical science and technology innovation, and help the city’s public hospitals to bridge the “last mile” of medical achievement transformation. It will also greatly promote the rapid development of the city’s biomedical industry across all levels of capacity, and will help Shanghai become a health science and technology innovation center with global influence and a model of a global health city, and help Shanghai become a science and technology innovation center with global influence as soon as possible.